Fundraising FoxAxonics Modulation Technologies
Irvine, US · Founded 2012 · 4 known investors
Find your way into Axonics Modulation Technologies
Sign up to see every warm intro you have to Axonics Modulation Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Axonics Modulation Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Boston Scientific develops medical devices and technologies used by healthcare professionals to treat patients across a range of conditions. The page (hosted on the axonics.com domain) presents the company as a medical device manufacturer focused on patient care.
Founders & leadership
Board
Investors · 4
How we know: Advent Life Sciences's portfolio page · Not right? Tell us
How we know: Andera Partners's portfolio page · Not right? Tell us
How we know: Longitude Capital's portfolio page · a partner's Signal profile · board seat on SEC Form D · the VCSheet dataset · Not right? Tell us
How we know: press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements$124.4M disclosed across 4 of 6 rounds · 2014–2020
- Undisclosed amountInitial Public OfferingOct 2018Source ↗
▶$55.1MraisedApr 2018 · 17 investors · Other TechnologyRule 506(b)
- John PetrovichDirector
- Raphael WisniewskiDirector
- Erik AmbleDirector
- Shahzad MalikDirector
- Raymond W. CohenExecutive Officer, Director
- Michael WilliamsonExecutive Officer
- Geoff PardoDirector
- Juliet Tammenoms BakkerDirector
- Dan L. DearenExecutive Officer
- Offering amount
- $55.1M
- Amount sold
- $55.1M
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$38.5MraisedDec 2015 · 14 investors · Other TechnologyRule 506(b)
- Erik AmbleDirector
- Raymond W. CohenExecutive Officer, Director
- Shahzad MalikDirector
- Michael WilliamsonExecutive Officer
- Dan L. DearenExecutive Officer
- Raphael WisniewskiDirector
- John PetrovichDirector
- Barry KeenanDirector
- Darren CaiDirector
- Offering amount
- $38.5M
- Amount sold
- $38.5M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$17.3MraisedApr 2015 · 8 investors · Other TechnologyRule 506(b)
- Darren CaiDirector
- Raphael WisniewskiDirector
- Michael WilliamsonExecutive Officer
- Erik AmbleDirector
- Raymond W. CohenExecutive Officer, Director
- Dan L. DearenExecutive Officer
- John PetrovichDirector
- David HankinDirector
- Offering amount
- $17.3M
- Amount sold
- $17.3M
- Proceeds to insiders
- $910K
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$13.5MraisedMar 2014 · 6 investors · Other TechnologyRule 506(b)
- David HankinDirector
- Robert GuezuragaDirector
- Michael V. WilliamsonExecutive Officer
- Raymond W. CohenExecutive Officer, Director
- Raphael WisniewskiDirector
- John G. PetrovichDirector
- Dan L. DearenExecutive Officer
- Offering amount
- $35M
- Amount sold
- $13.5M
- Minimum investment
- $200K
- Proceeds to insiders
- $800K
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Axonics Modulation Technologies do?
- Boston Scientific develops medical devices and technologies used by healthcare professionals to treat patients across a range of conditions. The page (hosted on the axonics.com domain) presents the company as a medical device manufacturer focused on patient care.
- Who are Axonics Modulation Technologies's investors?
- Axonics Modulation Technologies's investors include Advent Life Sciences, Andera Partners, Longitude Capital, Gilde Healthcare.
- How much funding has Axonics Modulation Technologies raised?
- Axonics Modulation Technologies has disclosed $124.4M raised across 4 of its 6 known rounds.
- Where is Axonics Modulation Technologies headquartered?
- Axonics Modulation Technologies is headquartered in Irvine, US.